The evidence described above suggested that pro-angiogenic SPP1+ TAMs may play a role in the EndMT process to facilitate intratumoral angiogenesis through the SPP1_CD44 interaction between SPP1+ TAMs and CAFEndMT and thus implied poor prognosis in cancer patients. The gene discussed is CD44; the disease is cancer.